MindMed Teams Up With Forian To Improve Real-World Evidence Data To Help Psychiatric Patients

Psychedelics-focused medicines company Mind Medicine Inc. (NASDAQ: MNMD), (NEO: MMED) announced Tuesday that it has teamed up with Forian Inc. (NASDAQ: FORA), a provider of evidence-based support for more comprehensive clinical and commercial decision-making.

MindMed and Forian will collaborate to develop best practices for using real-world evidence ("RWE") information to help improve the health and lives of psychiatric patients.

The New York-based company explained the importance of obtaining real-world health datasets, …

Full story available on Benzinga.com

More MindMed Teams Up With Forian To Improve Real-World Evidence Data To Help Psychiatric Patients